ReviewBiomaterials research2026
Female Reproductive Tract Modeling through Advanced 3D Biomimetic Platforms.
Review in Biomaterials research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The female reproductive tract (FRT) is an intricate and highly regulated network comprising the ovaries, fallopian tubes, uterus, cervix, and placenta, which work in concert to govern complex reproductive functions. Dysfunction within any of these organs can lead to serious pathological conditions, including infertility, pregnancy complications, and gynecological cancers. Although conventional 2-dimensional (2D) cultures and animal models have provided foundational insights, they are limited in their ability to recapitulate human-specific 3D tissue architecture and dynamic biochemical microenvironments. To address these limitations, organoid and organ-on-a-chip (OoC) technologies have emerged as a powerful 3D biomimetic platform. Organoids preserve epithelial identity, cellular heterogeneity, and patient-specific phenotypes, whereas OoC systems incorporate microfluidic flow, mechanical stimulation, and multicompartmental interfaces to model organ-level physiology. This review provides an organ-specific overview of recent advances in organoid and OoC systems across the FRT, discusses their advantages and current limitations relative to traditional models, and highlights their potential to transform reproductive biology research, disease modeling, and translational applications.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.